Universal Ibogaine (TSXV:IBO) YoY EBITDA Growth : -50.00% (As of Apr. 2024)

View and export this data going back to 2017. Start your Free Trial

What is Universal Ibogaine YoY EBITDA Growth?

YoY EBITDA Growth is the percentage change of EBITDA per Share over the past twelve months. Universal Ibogaine's YoY EBITDA Growth for the quarter that ended in Apr. 2024 was -50.00%.

Universal Ibogaine's EBITDA per Share for the three months ended in Apr. 2024 was C$-0.00.

Universal Ibogaine YoY EBITDA Growth Historical Data

The historical data trend for Universal Ibogaine's YoY EBITDA Growth can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Universal Ibogaine YoY EBITDA Growth Chart

Universal Ibogaine Annual Data

Trend

Mar17

Mar18

Mar19

Mar20

Mar21

Jul22

Jul23

YoY EBITDA Growth

Get a 7-Day Free Trial

53.33

28.57

-60.00

-587.50

81.82

Universal Ibogaine Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Oct21	Jan22	Apr22	Jul22	Oct22	Jan23	Apr23	Jul23	Oct23	Jan24	Apr24
YoY EBITDA Growth	Get a 7-Day Free Trial															66.67	95.00	100.00	75.00	-50.00

Universal Ibogaine YoY EBITDA Growth Calculation

YoY EBITDA Growth is the percentage change of EBITDA per Share over the past twelve months.

Universal Ibogaine's YoY EBITDA Growth for the fiscal year that ended in Jul. 2023 is calculated as:

	YoY EBITDA Growth (A: Jul. 2023 )
=	(EBITDA per Share (A: Jul. 2023 )	-	EBITDA per Share (A: Jul. 2022 ))	/	\| EBITDA per Share (A: Jul. 2022 ) \|
=	(-0.01	-	-0.055)	/	\| -0.055 \|
=	81.82 %

Universal Ibogaine's YoY EBITDA Growth for the quarter that ended in Apr. 2024 is calculated as:

	YoY EBITDA Growth (Q: Apr. 2024 )
=	(EBITDA per Share (Q: Apr. 2024 )	-	EBITDA per Share (Q: Apr. 2023 ))	/	\| EBITDA per Share (Q: Apr. 2023 )) \|
=	(-0.003	-	-0.002)	/	\| -0.002 \|
=	-50.00 %

Universal Ibogaine YoY EBITDA Growth Related Terms

Thank you for viewing the detailed overview of Universal Ibogaine's YoY EBITDA Growth provided by GuruFocus.com. Please click on the following links to see related term pages.

Universal Ibogaine Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Universal Ibogaine Inc (TSXV:IBO) » Definitions » YoY EBITDA Growth

Comparable Companies

Traded in Other Exchanges

IBOGF:USA JC4:Germany

Address

815 8th Avenue South West, Suite 600, Calgary, AB, CAN, T2P 3P2

Website

https://www.universalibogaine.com

Universal Ibogaine Inc develops a platform of addiction treatment clinics, which use ibogaine as a primary modality for the interruption and ideally cessation of addictions to primarily opioids such as oxycodone, heroin, fentanyl, as well as alcohol, cocaine, and other stimulants. It runs addiction clinics it has a research partner clinic in Mexico.

Executives

Ian Rabb

Senior Officer

Universal Ibogaine Headlines

From GuruFocus

DSS, Inc. Celebrates Impact BioMedical Inc.'s Successful IPO and Proudly Advances Shareholder Value

By Marketwired • 09-16-2024